European Alzheimer Academy Workshop

Bertinoro | Italy • 17-21 March 2024

European Alzheimer Academy Workshop

Bertinoro | Italy • 17-21 March 2024

European Alzheimer Academy Workshop

Bertinoro | Italy • 17-21 March 2024

Preliminary Programme

Preliminary Programme

  • Arrival and opening

    15:00-19:00

    Arrival and Registration of Participants

    19:00-19:45

    Opening Speech and Presentations AFI, AN, and FVA

    Coen van Deursen (EGM)
    Linda Thienpont (AFI)
    Minke Kooistra (AN)
    Marion Levy (FVA)

    19:45-20:30

    Welcome Buffet

    20:30

    Short Introduction Games/Presentations and Drinks

  • What is AD? What causes AD and what else is involved?

    8:00-8:10

    Opening

    Coen van Deursen (European Grant Manager AFI-AN-FVA)

    8:10-9:00

    Neuropsychological diagnosis and clinical symptoms of AD

    Kathrin Finke (Jena, Germany)

    9:00-9:50

    Etiology of AD: Amyloid, Tau, and Neuropathology

    Dietmar Thal (Leuven, Belgium)

    9:50-10:10

    Discussion with the participants

    Kathrin Finke (Jena, Germany)
    Dietmar Thal (Leuven, Belgium)

    10:10-10:30

    Coffee Break

    10:30-11:20

    Neuroinflammation and the Vascular System

    Elga de Vries (Amsterdam, the Netherlands)

    11:20-12:10

    Glia and early AD pathogenesis

    Mark Verheijen (Amsterdam, the Netherlands)

    12:10-12:30

    Discussion with the participants

    Elga de Vries (Amsterdam, the Netherlands)
    Mark Verheijen (Amsterdam, the Netherlands)

    12:30-13:40

    Lunch Break

    13:40-15:45

    Professional Development Session 1: Grant Writing 1
    All Monday Speakers, Faculty, and other available Speakers

    15:45-16:00

    Coffee Break

    16:00-22:00

    Social Activity (Vineyard Excursion)
    Dinner in the Village (Ca’ de Be’)

  • What is the role of genetics and life style factors in AD? What are novel advancements in preclinical AD research?

    8:00-8:50

    Genetics of AD

    Gaël Nicolas (Rouen, France)

    8:50-9:40

    Lifestyle Factors, Prevention, and AD

    Paul Lucassen (Amsterdam, the Netherlands)

    9:40-10:00

    Discussion with the participants

    Gaël Nicolas (Rouen, France)
    Paul Lucassen (Amsterdam, the Netherlands)

    10:00-10:20

    Coffee Break

    10:20-12:30

    Professional Development Session 2: How to find your research niche and become an independent researcher
    All Tuesday Speakers, Faculty, and other available Speakers

    12:30-13:40

    Lunch Break

    13:40-14:30

    Novel Advancements in Tau Research

    Wiep Scheper (Amsterdam, the Netherlands)

    14:30-15:10

    Novel Advancements in ApoE Research

    Henrietta Nielsen (Stockholm, Sweden)

    15:10-15:50

    The Importance of Gender and Diversity in AD Research

    Shireen Sindi (Stockholm, Sweden)

    15:50-16:10

    Coffee Break

    16:10-18:15

    Professional Development Session 3: Diversifying your research (population)
    All Tuesday Speakers, Faculty, and other available Speakers

    19:30

    Dinner at the Canteen

  • What will advancements in imaging and biomarker research mean for the AD field?

    8:15-9:10

    Advancements in the AD imaging field

    Louise van der Weerd (Leiden, the Netherlands)

    9:10-10:05

    Advancements in the AD fluid biomarker field

    Charlotte Teunissen (Amsterdam, the Netherlands)

    10:05-10:25

    Coffee Break

    10:25-11:20

    Advancements in the AD digital biomarker field

    David Berron (Magdeburg, Germany)

    11:20-12:30

    Discussion with the participants on the future of imaging and biomarker research in AD
    All Wednesday speakers

    12:30-13:40

    Lunch Break

    13:40-15:30

    Professional Development Session 4: Academic Mentorship
    All Wednesday speakers, Faculty, and other available Speakers

    15:30-16:00

    Coffee Break

    16:00-18:00

    Professional Development Session 5: Grant Writing 2
    All Wednesday speakers, Faculty, and other available Speakers

    19:30

    Pizza in the Village (La Grotta)

  • Will AD be treatable soon? What will AD treatment look like in the (near) future?

    9:00-10:30

    Keynote Lectures

    9:00-9:45

    Recent trial results in AD and what may follow

    Stefan Teipel (Rostock, Germany)

    9:45-10:30

    Opportunities and Opportunism in Alzheimer’s Disease Research

    Marcel Verbeek (Nijmegen, The Netherlands)

    10:30-10:50

    Coffee Break

    10:50-12:15

    Professional Development Session 6: Debate
    Keynote Speakers, Faculty, and other available Speakers
    Debate with prepared statements regarding the future directions of the AD research field

    12:15-12:30

    Closing the EAAW

    12:30

    Boxed Lunch Provided